BioPlus Acquisition Corp.
BIOS · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | $0 | $0 | -$1 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $0 | $1 | $0 |
| SG&A Expenses | $1 | $0 | -$1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $0 | -$1 | $0 |
| Operating Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3 | $3 | $2 | $1 |
| Pre-Tax Income | $1 | $2 | $2 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $2 | $2 | $1 |
| % Margin | – | – | – | – |
| EPS | 0.05 | 0.17 | 0.007 | 0.02 |
| % Growth | -70.6% | 2,328.6% | -65% | – |
| EPS Diluted | 0.05 | 0.17 | 0.06 | 0.02 |
| Weighted Avg Shares Out | 24 | 24 | 598 | 29 |
| Weighted Avg Shares Out Dil | 24 | 24 | 26 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $2 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |